XML 50 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per share
 12 Months Ended
Jun. 30, 2020
Text block [abstract]  
Earnings per share
Note 32. Earnings per share
 
 
 
  
2020
A$’000
 
  
2019
A$’000
 
  
2018
A$’000
 
Loss after income tax attributable to the owners of Kazia Therapeutics Limited
  
 
(12,467
) 
  
 
(10,270
) 
  
 
(6,039
) 
 
  
 
 
 
  
 
 
 
  
 
 
 
Loss after income tax attributable to the owners of Kazia Therapeutics Limited
  
 
(12,467
) 
  
 
(10,270
) 
  
 
(6,039
) 
 
  
 
 
 
  
 
 
 
  
 
 
 
    
 
  
Number
 
  
Number
 
  
Number
 
Weighted average number of ordinary shares used in calculating basic earnings per share
  
 
73,053,514
 
  
 
57,503,555
 
  
 
48,376,525
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Weighted average number of ordinary shares used in calculating Diluted earnings per share
  
 
73,053,514
 
  
 
57,503,555
 
  
 
48,376,525
 
 
  
 
 
 
  
 
 
 
  
 
 
 
    
 
  
Cents
 
  
Cents
 
  
Cents
 
Basic earnings per share
  
 
(17.07
) 
  
 
(17.86
) 
  
 
(12.48
) 
Diluted earnings per share
  
 
(17.07
) 
  
 
(17.86
) 
  
 
(12.48
) 
1,865,000 unlisted convertible notes with a face value of A$464,000 and 2,775,167 unlisted options have been excluded from the above calculations as they were antidilutive.